ZULATO, ELISABETTA

ZULATO, ELISABETTA  

Mostra records
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Aspirin-triggered DHA metabolites inhibit angiogenesis 2025 Trevisi, L.Zulato, E.Indraccolo, S.Bolego, C. + FRONTIERS IN PHARMACOLOGY - -
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC 2024 Zulato, ElisabettaPasello, GiuliaGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + SCIENTIFIC REPORTS - -
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer 2024 Boscolo Bragadin, AndreaZulato, ElisabettaPavan, AlbertoGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + NPJ PRECISION ONCOLOGY - -
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers 2024 Andrea Boscolo BragadinGiulia PaselloElisabetta ZulatoLaura BonannoStefano Indraccolo + THE JOURNAL OF LIQUID BIOPSY - -
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 2024 Fassan M.Zulato E. + ONCOLOGY AND THERAPY - -
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 2022 Dal Maso, ADel Bianco, PNardo, GZulato, EBonanno, LPasello, GIndraccolo, S + JOURNAL OF THORACIC DISEASE - -
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 2022 Bonanno, LauraDal Maso, AlessandroZulato, ElisabettaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Bonanno, L.Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 2021 Marra, LudovicaBonanno, LauraBoscolo, AliceDal Maso, AlessandroBoscolo Bragadin, AndreaIndraccolo, StefanoZulato, Elisabetta + FRONTIERS IN ONCOLOGY - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -
Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (Nsclc) patients 2021 Zulato E.Tosello V.Nardo G.Bonanno L.Del Bianco P.Indraccolo S. DIAGNOSTICS - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, StefanoBonanno, Laura + TRANSLATIONAL LUNG CANCER RESEARCH - -
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 2020 Nardo G.Zulato E.Bonanno L.Frega S.Indraccolo S. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 2020 Zulato, ElisabettaAttili, IlariaPavan, AlbertoDel Bianco, PaolaBoscolo Bragadin, AndreaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaAmadori, AlbertoConte, PierFrancoIndraccolo, StefanoBonanno, Laura + BRITISH JOURNAL OF CANCER - -
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach 2020 Piga I.Montenegro F.Nardo G.Zulato E.Del Bianco P.Indraccolo S. + FRONTIERS IN ONCOLOGY - -
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 2020 Zulato, ElisabettaFerro, AlessandraBoscolo, AliceAttili, IlariaFrega, StefanoDal Maso, AlessandroPasello, GiuliaGuarneri, ValentinaConte, Pier FrancoIndraccolo, StefanoBonanno, Laura + JOURNAL OF CLINICAL ONCOLOGY - -
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 2019 Pasello, GiuliaDal Maso, AlessandroLorenzi, MartinaScattolin, DanielaUrso, LoredanaZulato, ElisabettaFrega, StefanoBonanno, LauraIndraccolo, StefanoCalabrese, FiorellaConte, Pierfranco + JOURNAL OF CLINICAL ONCOLOGY - -
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer 2019 Bonanno, LauraZulato, ElisabettaPavan, AlbertoPasello, GiuliaIndraccolo, Stefano + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective 2019 Ciccarese F.Zulato E.Indraccolo S. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY - -
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 2019 Bonanno, L.Zulato, E.Attili, I.Del Bianco, P.Nardo, G.Boscolo Bragadin, A.Pasqualini, L.Calabrese, F.Fassan, M.Pasello, G.Guarneri, V.Conte, P.Indraccolo, S. + ANNALS OF ONCOLOGY - -